✦ LIBER ✦

BAVC regimen and autologous bone marrow transplantation for APL patients in second molecular remission: updated results

✍ Scribed by Capria, S; Latagliata, R; Avvisati, G; Breccia, M; Cimino, G; Diverio, D; Petti, M C; Meloni, G

Book ID: 110014629
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 71 KB
Volume: 36
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1704995

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Autologous Bone Marrow Transplantation f

Autologous Bone Marrow Transplantation for Patients with Acute Myelogenous Leukemia in Complete Remission

✍ G. MELONI; P. DE FABRITIIS; M. C. PETTI; A. PULSONI; A. SANDRELLI; A. COVELLI; F 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 283 KB

51 Conditioning regimens TN autologous b

51 Conditioning regimens TN autologous bone marrow transplantation for acute myeloid leukemia: Patient age and remission status influence choice of optimum conditioning regimen

✍ K.E. Dusenbery; M. Steinbuch; C. Litz; P.B. McGlave; N.K.C. Ramsay; B.R. Blazar; 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 101 KB

High-dose chemotherapy and unpurged auto

High-dose chemotherapy and unpurged autologous bone marrow transplantation for acute leukemia in second or subsequent remission

✍ Jorge A. Spinolo; Karel A. Dicke; Leonard J. Horwitz; Sundar Jagannath; Kenneth 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 710 KB

Rituximab with interleukin-2 after autol

Rituximab with interleukin-2 after autologous bone marrow transplantation for acute lymphocytic leukemia in second remission

✍ Ozsahin, Hulya ;Fluss, Jo�l ;Mc Lin, Valerie ;Wacker, Pierre ;Miralbell, Raymond 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 35 KB

To the Editor: Relapse is still a problem for leukemias, particularly in the autologous bone marrow transplantation (ABMT) setting. Moreover, the CD20 positive phenotype, de®ned as >20% expression, may be associated with a worse outcome [1]. Therefore, our experience with such a patient in whom we a

Idarubicin to intensify the conditioning

Idarubicin to intensify the conditioning regimens of autologous bone marrow transplantation for patients with acute myeloid leukemia in first complete remission

✍ Jerjis, Sh; Roovers, E; Muus, P; Schaap, N; de Witte, T 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 68 KB

Autologous and allogeneic bone marrow tr

Autologous and allogeneic bone marrow transplantation in acute myeloid leukemia in first complete remission: an update of the Genoa experience with 159 patients

✍ A. M. Carella; F. Frassoni; M. T. van Lint; F. Gualandi; D. Occhini; P. Carlier; 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 318 KB